AQR Capital Management
AURA icon

AQR Capital Management’s Aura Biosciences AURA Stock Holding History

AQR Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$780K Buy
109,889
+63,746
+138% +$456K ﹤0.01% 3147
2026
Q1 		$309K Buy
46,143
+32,281
+233% +$185K ﹤0.01% 3389
2025
Q4 		$75.5K Sell
13,862
-3,295
-19% -$19.6K ﹤0.01% 3482
2025
Q3 		$106K Sell
17,157
-478
-3% -$3.13K ﹤0.01% 3361
2025
Q2 		$110K Buy
+17,635
New +$103K ﹤0.01% 3159

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

AQR Capital Management's AURA Position: Q2 2026 in Review

AQR Capital Management increased its Aura Biosciences (AURA) stake by 138% in Q2 2026, buying an estimated $456K and bringing the position to 109,889 shares worth $780K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

AQR Capital Management first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • AQR Capital Management held 109,889 shares of Aura Biosciences worth $780K as of Q2 2026.
  • AQR Capital Management bought 63,746 Aura Biosciences shares in Q2 2026, an estimated $456K.
  • Aura Biosciences made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3147 holding.
  • AQR Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.